RC
IMA

Rangeley Capital’s ImageneBio Inc IMA Stock Holding History

Rangeley Capital’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Sell
20,090
-12,500
-38% -$70.6K 0.11% 146
2026
Q1 		$163K Buy
32,590
+14,346
+79% +$93.1K 0.16% 98
2025
Q4 		$126K Buy
18,244
+3,244
+22% +$24.1K 0.1% 101
2025
Q3 		$122K Buy
+15,000
New +$199K 0.11% 107

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Rangeley Capital's IMA Position: Q2 2026 in Review

Rangeley Capital reduced its ImageneBio Inc (IMA) stake by 38% in Q2 2026, selling an estimated $70.6K and leaving 20,090 shares worth $119K. The position accounts for 0.11% of the portfolio, ranked #146.

Rangeley Capital first reported a position in IMA in Q3 2025 and has held it in 4 quarters since. The position peaked at $163K in Q1 2026. 35 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • Rangeley Capital held 20,090 shares of ImageneBio Inc worth $119K as of Q2 2026.
  • Rangeley Capital sold 12,500 ImageneBio Inc shares in Q2 2026, an estimated $70.6K.
  • ImageneBio Inc made up 0.11% of Rangeley Capital's portfolio in Q2 2026, its #146 holding.
  • Rangeley Capital first reported a position in ImageneBio Inc in Q3 2025 and has held it in 4 quarters since.
  • Rangeley Capital's ImageneBio Inc position peaked at $163K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.